RECRUITING

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.

Official Title

Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Quick Facts

Study Start:2022-11-29
Study Completion:2027-05-25
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05519878

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 18 and over
  2. * Sufficiently fluent in English
  3. * On active treatment receiving systemic therapy (e.g., chemotherapy, immunotherapy, hormonal therapy, etc.) or radiotherapy
  4. * Patients with diagnosis of a genitourinary (GU) cancer (e.g., prostate, kidney, and bladder cancer) who have grade 1 or 2 fatigue based on physician assessment at the time of study entry
  5. * Clinician assessed prognosis of greater than or equal to six months
  6. * Willing and independently able to provide consent
  7. * Receive a pre-screen FACIT-Fatigue score of less than or equal to 30
  1. * Severe sleep disorders (e.g. narcolepsy)
  2. * Eye Diseases which limit the ability of light to be processed (e.g. untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems or other retinal disorder)
  3. * Severe psychological impairment (e.g., bipolar disorder or manic episodes)
  4. * Current employment in night shift work
  5. * Previous use of light therapy to alleviate fatigue or depressive symptoms
  6. * Secondary cancer diagnosis within the past 5 years
  7. * Plans to travel across meridians during treatment
  8. * Pregnancy
  9. * Currently recovering from previous eye surgery within the past 6 months that causes eye irritation
  10. * Sensitivity to light, epilepsy, or a history of seizures

Contacts and Locations

Principal Investigator

William Dale
PRINCIPAL_INVESTIGATOR
City of Hope Medical Center

Study Locations (Sites)

City of Hope Medical Center
Duarte, California, 91010
United States

Collaborators and Investigators

Sponsor: City of Hope Medical Center

  • William Dale, PRINCIPAL_INVESTIGATOR, City of Hope Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-29
Study Completion Date2027-05-25

Study Record Updates

Study Start Date2022-11-29
Study Completion Date2027-05-25

Terms related to this study

Additional Relevant MeSH Terms

  • Bladder Carcinoma
  • Genitourinary System Neoplasm
  • Kidney Carcinoma
  • Prostate Carcinoma